MS designed the strategy
MS designed the strategy. risk of reinfection from fresh variants. Here, we targeted to investigate the feasibility of redirecting existing mAbs against fresh variants of SARS-CoV-2, as well as to understand how BQ.1.1 and XBB.1.5 can evade broadly neutralizing mAbs. By mapping epitopes and escape sites, we discovered that the new variants evade multiple mAbs,…